The import of antisera and other blood fractions to Germany is projected to increase from 21.707 million kilograms in 2024 to 24.261 million kilograms in 2028. This represents a consistent year-on-year growth. Between 2024 and 2025, the volume is forecasted to grow by approximately 3.03%, while from 2025 to 2026 the growth is estimated at 2.88%. Between 2026 and 2027, an increase of 2.75% is expected, and from 2027 to 2028, the growth is projected at 2.63%. Over the five-year period, the compound annual growth rate (CAGR) stands at approximately 2.81%.
Key future trends to watch include:
- Advancements in medical technology could drive increased demand for advanced blood fraction products.
- Regulatory changes within the EU may impact import practices and standards.
- Developments in global healthcare R&D will likely influence the dynamic of the import market.
